FOLH1 and cancer: Detection using PSMA antibody also increased cancer detection specificity as the CD63 captured S‐EVs from LPCa and AdvPCa were significantly higher than in benign samples (PSMA+ CD63+ CD9+; Figure 1c, **P < 0.01, ***P < 0.001).